SCHEMBL22100210

SCHEMBL22100210

c1ccc(-c2nc(-c3cccc4c3-c3ccccc3C43c4ccccc4Sc4ccccc43)nc(-c3cccc4ccccc34)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 3/20 0.39
TSHR P16473 2/20 0.39
MAPK1 P28482 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
ATM Q13315 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAB9A P51151 3/20 0.32
NPC1 O15118 2/20 0.32
LMNA P02545 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965368 0.95 TSHR (0.38) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23965328 0.95 KDM4E (0.38) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL22100201 0.94 KDM4E (0.32) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23965332 0.93 KDM4E (0.36) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23965372 0.93 KDM4E (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL21151976 0.93 TSHR (0.36) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23965156 0.92 KDM4E (0.39) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL22908169 0.90 ALOX15 (0.35) MAPTKDM4EALDH1A1HPGDTSHR
SCHEMBL21151252 0.90 ALOX15 (0.35) MAPTKDM4EALDH1A1HPGDTSHR
SCHEMBL22059316 0.90 ALDH1A1 (0.44) MAPTSMN1; SMN2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-28 US disclosed
WO-2020122384-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2020-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNL2, MCM6, CRY1 MAPT 3677/4885SMN1; SMN2 3471/4885KDM4E 2468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.